At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 689 enrolled
Drug / intervention
tamsulosindrug
Likely dose
tamsulosin 0.4 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
In Brief
A Phase 2 clinical trial evaluating tamsulosin for Lower Urinary Tract Symptoms. Completed, enrolled 689 participants across 18 sites.
Detailed Summary
Multicenter trial conducted in Pharmacy retail centers
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLower Urinary Tract Symptoms
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2012
First PostedNov 2012
Primary CompletionMar 2013
TodayJul 2026
First PostedNov 14, 2012
Enrollment StartNov 1, 2012
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 13.6 years ago
Interventions
tamsulosindrug
0.4 mg